Geron reported $-236K in EBIT for its fiscal quarter ending in March of 2026.





Ebit Change Date
Amgen USD 4.61B 777M Jun/2026
Bio Techne USD 75.49M 21.03M Mar/2026
Cassava Sciences USD -11.17M 2.38M Mar/2026
Cytokinetics USD -179.17M 2.05M Jun/2026
Exelixis USD 248.41M 2.93M Jun/2026
Genmab DKK 407M 221M Jun/2026
Geron USD -236K 10.55M Mar/2026
Gilead Sciences USD 3.85B 1.17B Jun/2026
Incyte USD 700.4M 356.23M Jun/2026
MacroGenics USD -31.88M 19.79M Mar/2026
Novartis USD 4.73B 549M Jun/2026
Novavax USD 20.94M 100.32M Dec/2025